Medicare Enrolled

Dr. Lucas Heller, M.D.

Endocrinology · Irwin, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
8775 NORWIN AVE STE 100, Irwin, PA 15642
8336047211
In practice since 2012 (14 years)
NPI: 1982970976 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Heller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Heller? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Heller

Dr. Lucas Heller is an endocrinology specialist in Irwin, PA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Heller performed 215 Medicare services across 176 unique beneficiaries.

Between the years covered by Open Payments, Dr. Heller received a total of $162,961 from 34 pharmaceutical and/or device companies across 653 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Heller is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ 215 Medicare services $162,961 industry payments

Medicare Practice Summary

Medicare Utilization ↗
215
Medicare services
Bottom 22% in PA for endocrinology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
176
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~15 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
144 $81 $199
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
36 $125 $278
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $59 $140
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $94 $218
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$162,961
Total received (2018-2024)
Avg $23,280/year across 7 years
Top 7% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
653
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$158,617 (97.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,344 (2.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$19,845
2023
$16,938
2022
$55,938
2021
$51,062
2020
$16,593
2019
$2,062
2018
$523

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$19,539
Astellas Pharma US Inc
$99
Lilly USA, LLC
$43
Tandem Diabetes Care, Inc.
$33
Amneal Pharmaceuticals LLC
$22
ABBVIE INC.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Dexcom, Inc.
$16
BETA BIONICS, INC.
$15
AstraZeneca Pharmaceuticals LP
$14
Verity Pharmaceuticals Inc.
$14
Amgen Inc.
$14
Top 3 companies account for 99.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$144,024
Boehringer Ingelheim Pharmaceuticals, Inc.
$9,276
Lilly USA, LLC
$6,815
AstraZeneca Pharmaceuticals LP
$705
Amgen Inc.
$308
Merck Sharp & Dohme Corporation
$207
Amneal Pharmaceuticals LLC
$187
SANOFI-AVENTIS U.S. LLC
$161
Abbott Laboratories
$131
Medtronic MiniMed, Inc.
$124
Janssen Pharmaceuticals, Inc
$113
Astellas Pharma US Inc
$99
IBSA Pharma Inc.
$70
Shire North American Group Inc
$68
Becton, Dickinson and Company
$64
Tandem Diabetes Care, Inc.
$63
Amarin Pharma Inc.
$50
Cumberland Pharmaceuticals, Inc.
$47
AbbVie, Inc.
$44
Bayer HealthCare Pharmaceuticals Inc.
$42
Corcept Therapeutics
$39
Dexcom, Inc.
$39
Insulet Corporation
$37
Clarus Therapeutics Inc.
$35
Antares Pharma, Inc.
$32
Xeris Pharmaceuticals, Inc.
$30
AbbVie Inc.
$29
Medtronic, Inc.
$28
ABBVIE INC.
$20
Horizon Therapeutics plc
$18
BETA BIONICS, INC.
$15
Verity Pharmaceuticals Inc.
$14
Radius Health, Inc.
$13
LifeScan, Inc.
$12
Top 3 companies account for 98.3% of all-time payments
Associated products mentioned in payments ›
BAQSIMI · BASAGLAR · BD NANO · BD Nano · Caldolor · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · HUMULIN · HUMULIN R 500 · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · MINIMED 780G · MOUNJARO · Minimed 530G · Minimed 630G · Minimed 670G System · NATPARA (PARATHYROID HORMONE) · NOCDURNA · Omnipod · OneTouch · Ozempic · Prolia · RAYOS · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SYNJARDY · SYNTHROID · Saxenda · Synthroid · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · Vascepa · Veozah · Victoza · Wegovy · XYOSTED · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for endocrinology in PA.

Looking for an endocrinology specialist in Irwin?
Compare endocrinologists in the Irwin area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
68
Per 100K population
19.2
County median income
$72,468
Nearest hospital
UPMC MCKEESPORT HOSPITAL
6.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Heller is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 7% of PA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Heller experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Heller performed 144 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Heller receive payments from pharmaceutical companies?
Yes. Dr. Heller received a total of $162,961 from 34 companies across 653 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Heller's costs compare to other endocrinologists in Irwin?
Dr. Heller's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Heller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →